Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Host cell receptors for HSV-1 entry are a diverse group of cell surface molecules that facilitate the multi-step process of Herpes Simplex Virus type 1 (HSV-1) infection. The process begins with the attachment of viral glycoproteins gB and gC to heparan sulfate proteoglycans (HSPGs) on the host cell surface [1, 9]. This is followed by the binding of viral glycoprotein D (gD) to one of several specific entry receptors, including Nectin-1 (also known as Poliovirus receptor-related protein 1), Herpesvirus entry mediator (HVEM, a member of the TNF receptor superfamily), or 3-O-sulfated heparan sulfate [2, 3, 7]. These interactions trigger a conformational change in gD that recruits the core fusion machinery (gB and the gH/gL complex), leading to the fusion of the viral envelope with the host plasma membrane or endosomal membrane [1, 12]. Different receptors are utilized depending on the cell type; for example, Nectin-1 is the primary receptor for epithelial and neuronal cells, while HVEM is critical for entry into T lymphocytes [3, 12]. Targeting these receptors or their interactions with viral glycoproteins is a key area of antiviral research, with drugs like docosanol acting as fusion inhibitors and various experimental peptides and small molecules designed to block attachment or receptor binding [4, 10, 18].
Inhibition of viral-host membrane fusion, blocking of viral attachment to cell surface proteoglycans, and downregulation of receptor expression.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Herpes simplex virus 1 entry receptors.